Management of Diabetic Nephropathy

Diabetic nephropathy is the single most common cause of end-stage renal disease in the western world and is associated with greatly increased cardiovascular morbidity and mortality. With the rising prevalence of type 2 disease it has come to pose a heavy burden on healthcare systems worldwide. Investment in fundamental and clinical research has yielded strategies that can reduce the risk of diabetic renal disease and slow its progression.